Adlai Nortye Group Ltd. American Depositary Shares (ANL) Stock Price
ANLStock
$13.82+724.58%52W
Market Cap$889.98M
P/E—
PEG Ratio—
Div yield—
Beta1.34
ANL Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)24.63%
Price vs S&P 500 (4W)4.85%
VGM Score78.38
ANL Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.14
4.22
4.20
4.20
Industry Peers — Pharmaceuticals(570)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ANLAdlai Nortye Group Ltd. American Depositary Shares | — | — | B | $13.82 |
| LLYEli Lilly & Co. | D | B | C | $1174.61 |
| JNJJohnson & Johnson | D | C | B | $268.04 |
| ABBVABBVIE INC. | D | C | B | $255.48 |
| MRKMerck & Co., Inc. | D | C | B | $148.35 |
| NVSNovartis AG | C | C | C | $153.81 |
| AZNAstraZeneca PLC | C | B | C | $162.70 |
| NVONovo-Nordisk A/S | B | C | C | $45.61 |
| ABTAbbott Laboratories | C | C | C | $112.47 |
| PFEPfizer Inc. | C | D | B | $27.96 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $541.69 |
About Adlai Nortye Group Ltd. American Depositary Shares
Adlai Nortye Ltd is a clinical-stage biotech company developing cancer therapies targeting multiple tumor types. The company's pipeline comprises three clinical-stage drug candidates and three preclinical assets.